Sort
78,016 grants matching “breast cancer”
Molecular Basis of Aneuploidy
$459,538Debananda Pati · Baylor College Of Medicine · R01 · FY2009 · CA
SCOTT AND WHITE COMMUNITY CLINICAL ONCOLOGY PROGRAM
$459,536Scott And White Memorial Hospital · U10 · FY2000 · CA
Mechanism(s)of antitumor action of tamoxifen and soy
$459,530University Of Illinois At Chicago · R01 · FY2003 · CA
IBCSG STATISTICAL CENTER--A BREAST CANCER STUDY RESOURCE
$459,529Richard D Gelber · Dana-Farber Cancer Inst · U24 · FY2007 · CA
BARD1 AND BREAST CANCER PATHOGENESIS
$459,489Columbia University Health Sciences · R01 · FY2001 · CA
Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins
$459,464Weidong Wang · National Institute On Aging · ZIA · FY2010 · AG
NONINVASIVE SUBHARMONIC PRESSURE ESTIMATION FOR MONITORING BREAST CANCER RESPONSE TO NEOADJUVANT THERAPY.
$459,417Thomas Jefferson University · · FY2008 · Department of the Army
Combined Biologic and Radiopharmaceutical Therapy of Breast Cancer
$459,386George Sgouros · Johns Hopkins University · R01 · FY2019 · CA
COMMON AND RARE SEQUENCE VARIANTS IN BREAST CANCER RISK
$459,385Sean Vahram Tavtigian · University Of Utah · R01 · FY2010 · CA
Novel roles of STAT2 and IFN-I in tumorigenesis and responses to therapy
$459,381George Robert Stark · Cleveland Clinic Lerner Com-Cwru · P01 · FY2024 · CA
VEGFs in tumor lymphatic metastasis
$459,337Laura E Benjamin · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA
Lifestyle associated reactive metabolites and their negative impact on breast cancer risk
$459,328Victoria Jane Findlay · Medical University Of South Carolina · R01 · FY2020 · CA
Regulation of Metastasis and Angiogenesis by Autotaxin and its Products
$459,314Mary Stracke · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
A novel breast cancer therapy based on secreted protein ligands from CD36+ fibroblasts
$459,309Bahram A. Parvin · University Of Nevada Reno · R01 · FY2023 · CA
Targeting EGFR/FOXG1-mediated resistance to ONC201 in H3K27M-mutant diffuse midline glioma
$459,296Carl J Koschmann · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
SOY EFFECTS ON ESTROGENS AND MAMMOGRAPHIC DENSITIES
$459,278University Of Hawaii At Manoa · R01 · FY2002 · CA
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$459,263Mobile Infirmary Medical Center · U10 · FY2003 · CA
Tumor Immunology & Host Response
$459,262Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2013 · CA
Building Interdisciplinary Research Careers in Women's Health
$459,244Nancy Catherine Andrews · Duke University · K12 · FY2015 · HD
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$459,209Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer
$459,197Lewis C Cantley · Beth Israel Deaconess Medical Center · P01 · FY2007 · CA
Whole Genome Association Study of Mammographic Density
$459,193Rulla M Tamimi · Brigham And Women'S Hospital · R01 · FY2009 · CA
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
$459,167Linnie Golightly · Weill Medical Coll Of Cornell Univ · R33 · FY2023 · HL
New Leads for Triple Negative Breast Cancer from Diverse Natural Sources
$459,144Susan L Mooberry · University Of Texas Hlth Science Center · U01 · FY2018 · CA
New Leads for Triple Negative Breast Cancer from Diverse Natural Sources
$459,144Susan L Mooberry · University Of Texas Hlth Science Center · U01 · FY2015 · CA